Status:
WITHDRAWN
Study the Safety and Efficacy of Probiotics Use in Premature Infants
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Lallemand Health Solutions
Conditions:
Infant, Premature, Diseases
Eligibility:
All Genders
Up to 2 years
Phase:
NA
Brief Summary
Prophylactic enteral probiotics may enhance clinical markers and biomarkers of preterm infants' health, and may also play a role in reducing NEC and associated morbidity.
Eligibility Criteria
Inclusion
- born with weight\<1500 g
- hospitalized within 48 hours after birth
Exclusion
- present with evidence or suspicion of congenital intestinal obstruction
- perforation
- gastroschisis
- large omphalocele
- congenital diaphragmatic hernia
- major congenital heart defects
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01891604
Last Update
May 12 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.